TriangleHEALTH PROFESSIONAL · SOURCE READING
Supraglottis
Source: Laryngeal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 14, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Stage II Laryngeal Cancer
Treatment options for stage II cancer of the supraglottis include:
External-beam radiation therapy alone for the smaller lesions encompassing the primary disease and regional elective nodes.[1]
Source links and citations
Supraglottic laryngectomy with bilateral neck dissections, depending on location of the lesion, clinical status of the patient, and expertise of the treatment team. Careful selection must be made to ensure adequate pulmonary and swallowing function postoperatively.
Postoperative radiation therapy (PORT) is indicated for positive or close surgical margins or other adverse pathological risk factors.
Radiation therapy should be preferred because of the good results, preservation of the voice, and the possibility of surgical salvage in patients whose disease recurs locally.
Preserved source evidence · Not medical advice